125 related articles for article (PubMed ID: 28551101)
1. Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20' ethyl substituent.
Allemann O; Cross RM; Brütsch MM; Radakovic A; Boger DL
Bioorg Med Chem Lett; 2017 Jul; 27(14):3055-3059. PubMed ID: 28551101
[TBL] [Abstract][Full Text] [Related]
2. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20' urea derivatives.
Leggans EK; Duncan KK; Barker TJ; Schleicher KD; Boger DL
J Med Chem; 2013 Feb; 56(3):628-39. PubMed ID: 23244701
[TBL] [Abstract][Full Text] [Related]
3. Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.
Carney DW; Lukesh JC; Brody DM; Brütsch MM; Boger DL
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9691-8. PubMed ID: 27512044
[TBL] [Abstract][Full Text] [Related]
4. New prospects for vinblastine analogues as anticancer agents.
Silvestri R
J Med Chem; 2013 Feb; 56(3):625-7. PubMed ID: 23316748
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives.
Va P; Campbell EL; Robertson WM; Boger DL
J Am Chem Soc; 2010 Jun; 132(24):8489-95. PubMed ID: 20518465
[TBL] [Abstract][Full Text] [Related]
6. Ultra-potent vinblastine analogues improve on-target activity of the parent microtubulin-targeting compound.
Radakovic A; Boger DL
Bioorg Med Chem Lett; 2019 Jun; 29(11):1370-1374. PubMed ID: 30952593
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.
Ishikawa H; Colby DA; Seto S; Va P; Tam A; Kakei H; Rayl TJ; Hwang I; Boger DL
J Am Chem Soc; 2009 Apr; 131(13):4904-16. PubMed ID: 19292450
[TBL] [Abstract][Full Text] [Related]
8. Potent Vinblastine C20' Ureas Displaying Additionally Improved Activity Against a Vinblastine-Resistant Cancer Cell Line.
Barker TJ; Duncan KK; Otrubova K; Boger DL
ACS Med Chem Lett; 2013 Sep; 4(10):985-8. PubMed ID: 24223237
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of C-13' substituted 7'-homo-anhydrovinblastine derivatives.
Gherbovet O; La Spisa F; Thoret S; Alvarez MCG; Levaique H; Bignon J; Roussi F
Bioorg Med Chem Lett; 2015 Apr; 25(8):1771-1773. PubMed ID: 25804719
[TBL] [Abstract][Full Text] [Related]
10. Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.
Lukesh JC; Carney DW; Dong H; Cross RM; Shukla V; Duncan KK; Yang S; Brody DM; Brütsch MM; Radakovic A; Boger DL
J Med Chem; 2017 Sep; 60(17):7591-7604. PubMed ID: 28857558
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the regulation of tubulin by vinblastine.
Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
[TBL] [Abstract][Full Text] [Related]
12. High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs.
Radakovic A; Boger DL
Bioorg Med Chem Lett; 2018 Mar; 28(5):863-865. PubMed ID: 29439899
[TBL] [Abstract][Full Text] [Related]
13. One-pot synthesis of vinca alkaloids-phomopsin hybrids.
Gherbovet O; Coderch C; García Alvarez MC; Bignon J; Thoret S; Guéritte F; Gago F; Roussi F
J Med Chem; 2014 Jun; 57(12):5470-6. PubMed ID: 24871162
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
Potier P
Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
[No Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of a new series of highly functionalized 7'-homo-anhydrovinblastine derivatives.
Gherbovet O; Coderch C; García Alvarez MC; Bignon J; Thoret S; Martin MT; Guéritte F; Gago F; Roussi F
J Med Chem; 2013 Aug; 56(15):6088-100. PubMed ID: 23822556
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.
Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH
J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938
[TBL] [Abstract][Full Text] [Related]
17. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
Chi S; Xie W; Zhang J; Xu S
J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192
[TBL] [Abstract][Full Text] [Related]
18. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis of a key series of vinblastines modified at C4 that define the importance and surprising trends in activity.
Yang S; Sankar K; Skepper CK; Barker TJ; Lukesh JC; Brody DM; Brütsch MM; Boger DL
Chem Sci; 2017 Feb; 8(2):1560-1569. PubMed ID: 28194270
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship studies of cytotoxic ester and ether anhydrovinblastine derivatives.
Zhang HK; Shao Y; Ding H; Hu LH
J Nat Prod; 2008 Oct; 71(10):1669-76. PubMed ID: 18771244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]